Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.38 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.38 |
| ▸ | THRA | P10827 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 3/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5586948 | 0.89 | PDE2A (0.33) | LTA4HGABRA1GABRB2 | |
| SCHEMBL5589058 | 0.83 | THRA (0.37) | THRATHRBESR1FFAR1 | |
| SCHEMBL5589648 | 0.80 | GABRA1 (0.34) | GABRA1GABRB2 | |
| SCHEMBL5588832 | 0.79 | HPGD (0.44) | LTA4HNR5A1THRATHRBESR1 | |
| SCHEMBL5587271 | 0.77 | GABRA1 (0.36) | LTA4HNR5A1GABRA1GABRB2ESR1 | |
| SCHEMBL5586663 | 0.76 | LTA4H (0.39) | LTA4HNR5A1THRATHRBESR1 | |
| SCHEMBL5590537 | 0.76 | LTA4H (0.39) | LTA4HNR5A1THRATHRBESR1 | |
| SCHEMBL5589063 | 0.74 | LTA4H (0.38) | LTA4HNR5A1THRATHRBESR1 | |
| SCHEMBL5588202 | 0.74 | ALOX5 (0.41) | LTA4HNR5A1THRATHRBESR1 | |
| SCHEMBL5589074 | 0.74 | LTA4H (0.38) | LTA4HNR5A1THRATHRBESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | disclosed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | disclosed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | LTA4H 147/4885NR5A1 2413/4885THRA 3787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.